Chloramphenicol eye drops, boron, infants and fertility

The editorial discusses some pragmatic points about the change in licensing of chloramphenicol eye drops, which are no longer indicated for use in children <2 years. It comments that the communication of this major change has been poor and that the risks of this are many.

Drug and Therapeutics Bulletin